Most Recent Discussions

Sep 25 2020

Re: Rocklatan FDA Approved

Curious, I just started a patient (my first with this therapy) on Rocklatan after getting ZERO IOP change on generic Xalatan. He has been using it correctly for no more than two weeks but is complaining of bloodshot eyes. Is
read more

 

Jul 10 2018

Re: Longitudinal Study of Corneal Hysteresis

Great article, Jim, thanks.

 

Nov 27 2017

Re:

 
 

Clinician Topics

Glaucoma Watch
Interesting Glaucoma Cases
From Ocular Hypertension to Glaucoma: How to Predict Conversion
Neckties and IOP: The Controversy Continues
Introduction to the National Glaucoma Society
Case Presentation: Optic Nerve Imaging
NGS Residency Award and Lecture
Optic Nerve Head Measurements with the HRT III
Case Presentation: Laser Imaging Detects Early ON Damage
Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?
Interview with Dr. Barry Barresi
Glaucoma Continuum
Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study
The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older
Altered Nitric Oxide System in Patients with Open-Angle Glaucoma
Oxidative Stress in Glaucoma: A Burden of Evidence
Gonioscopy Videos
Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women
Programs to Optimize Adherence in Glaucoma
Corneal Hysteresis
Visual Field Interpretation
Study Questions link between Glaucoma and Alzheimer's Disease
Checking Color Vision
IOP Asymmetry as Glaucoma Risk Factor
Glaucoma Risk Calculators
Dr. David Calkins Discusses Catalyst for A Cure
Smart Phone Biosensor
Handheld OCT
Sustained Release IOP Therapies
Introduction to Corneal Hysteresis
FDT Perimetry
Visual Fields Overview
National Glaucoma Symposium 2017
Gonioscopy Slides from 2017 National Glaucoma Symposium
Measuring Corneal Hysteresis
XEN Glaucoma Implant Video
Corneal Hysteresis
Glaucoma Quality of Life Measures
Corneal Hysteresis: The A1C of Glaucoma
Predicting Progression
New Developments in Glaucoma Management
SECO Session on Innovations in Glaucoma
Longitudinal Study of Corneal Hysteresis
National Glaucoma Symposium 2018
DREAM Study
OIS at SECO
National Glaucoma Symposium Cape Cod
Is Glaucoma a Two-Pressure Disease?
ICD Stage Definitions
Visual Fields and Progression
OCT: The Basics
Co-Managing Glaucoma Surgery
Normal Tension Glaucoma
The Importance of Visual Fields
Corneal Hysteresis
Using OCT in Glaucoma Management
The LiGHT Study
In Your Office
Glaucoma Flowsheet
Tonometer Calibration
Pachymetry Coding
BCBS Coverage of SCODI Services
Expanded Coverage of Glaucoma Screening Services
Coding Update: 92135 Deleted and Replaced
ABO Certification Review Materials
Small Fee Reduction in CMS Payments in 2015
Moist Heat Compresses
Information about Omega-3s
Glaucoma Website for Patients
Beware of Phone Scam Posing as DPH or DEA
Pharmacology Update
Extravan: Alcon Pharmaceuticals
Mechanism of IOP Reduction with Travoprost
Clinical Guidelines
CCT: Is is time to say YES?
The Role of CCT in Glaucoma Patients
More CCT
The Paradox of IOP
Should We Treat All Ocular Hypertensives?
Beta Blockers in Glaucoma Management
Re-Defining Ocular Hypertension
Implications of Macro-Disc Asymmetry in Glaucoma Suspects
Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
CyPass Clinical Recommendations
Industry News
New FDA Approval for Lumigan
Alcon's Travatan Z Solution Receives FDA Approval
Alcon's Travatan Z and Systane Use Different Preservatives
Pfizer Sponsors New "All Eyes on Glaucoma" Website
CLIA Waivers
Bausch + Lomb New Glaucoma Drug
Glaukos iStent inject FDA Approved
Alcon Withdraws CyPass Stents
Nuretin Omega-3 Supplements
Rocklatan FDA Approved
Vivid Vision Perimetry
Falck Multifunction Device